Autopsy report · NCT00990197

The Safety of Transdermal Nicotine Immediately Following an Acute Coronary Syndrome

“Difficulties with enrollment.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 years 4 months after it had already started.
• Suspended: paused, and may or may not restart.
• 30 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Na

Sponsor

Sir Mortimer B. Davis - Jewish General Hospital

Sponsor type

University, hospital or other

Conditions

Smoking Cessation

Interventions

Transdermal nicotine patch

Participants

30 (planned, not actual)

Sites

1

Countries

Canada

Trials that died the same way

• AVAD: Asthma With Small Airways Dysfunction
  “difficulties of enrollment” (97% match in meaning)
• Clinical Trial With Mesalamine 1g Suppositories
  “Enrollment difficulties” (95% match in meaning)
• A Prospective, Single-center, Randomized, Controlled Study of Sevelamer Carbonate in the Lipid Metabolism and Uric Acid Treatment of Obesity-Related Glomerulopathy
  “difficulty in enrollment” (93% match in meaning)
• Tiotropium vs. Inhaled Corticosteroids in Children With Nonatopic Asthma Pilot Study (TioNAAP)
  “Difficult enrollment” (92% match in meaning)
• Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease
  “Difficulty with enrollment” (91% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.